In addition, QKI and RBFOX1 overexpression also significantly increased the CD44-high cell populations in two additional breast cancer cell lines (MCF7 and ZR75-1) (Figure 2—figure supplement 3B). This evidence concerns the gene CD44 and breast carcinoma.